April 29, 2021-Pfizer CEO Albert Bourla says the oral drug the company is developing to treat the symptoms of COVID-19 may be open to the public...
This drug was effective when provided 12 hours before or 12 hours after SARS-CoV-2 infection. Orally administered antivirals, first developed to treat influenza, have the potential...
New Delhi: While the world is fixing hope vaccine To control the covid-19 pandemic, researchers at the Institute of Biomedical Sciences at Georgia State University have...
Recent Comments